Gamma Knife metrics
| Metric | Statistics (if available) |
|---|---|
| Cumulative number of patients treated by indication category | 809 900 through 2013, up from 740 200 through 2012 Malignant tumours: 354 500 through 2013 Benign tumours: 295 600 through 2013 Functional disorders: 60 000 through 2013 Vascular disorders: 96 800 through 2013 Ocular disorders: 3100 through 2013 |
| Number of patients treated by indication category | 69 700 patients treated in 2013, up from 65 900 in 2012 Malignant tumours: 30 000 in 2013 Benign tumours: 27 300 in 2013 Functional disorders: 5200 in 2013 Vascular disorders: 6900 in 2013 Ocular disorders: 200 in 2013 |
| Relative distribution of indications per year | 43% malignant tumours, 39% benign tumours, 10% vascular disorders, 7% functional disorders, 1% ocular disorders |
| Cumulative number of patients treated by indication (North America) | Malignant tumours: 99 700 (48%) Benign tumours: 59 100 (28%) Functional disorders: 33 200 (16%) Vascular disorders: 15 900 (8%) Other indications 100 (0%) |
| Accumulated treatments by region and indication | Asia excl. Japan: 58 533 malignant tumours, 109 143 benign tumours, 35 986 vascular disorders, 11 292 functional disorders, 334 ocular disorders North America: 99 690 malignant tumours, 59 073 benign tumours, 15 937 vascular disorders, 33 232 functional disorders, 113 ocular disorders Japan: 141 032 malignant tumours, 39 155 benign tumours, 14 752 vascular disorders, 4797 functional disorders, 98 ocular disorders Europe: 52 424 malignant tumours, 76 234 benign tumours, 26 379 vascular disorders, 9762 functional disorders, 2437 ocular disorders Latin America: 956 malignant tumours, 1878 benign tumours, 1539 vascular disorders, 260 functional disorders, 52 ocular disorders Middle East and Africa: 1900 malignant tumours, 10 080 benign tumours, 2299 vascular disorders, 608 functional disorders, 20 ocular disorders |
| Average treatments per site and total number of treatments by region | 2013 average treatments per site: 263 Asia excluding Japan: 374 average treatments per site, 19 436 total number of treatments North America: 154 average treatments per site, 16 635 total number of treatments Japan: 237 average treatments per site, 12 797 total number of treatments Europe: 478 average treatments per site, 17 672 total number of treatments Latin America: 104 average treatments per site, 731 total number of treatments Middle East and Africa: 352 average treatments per site, 2462 total number of treatments |
| Treatments by region | Cumulative number of patients treated per year: Asia excluding Japan—215 200 through 2013; 195 800 through 2012 Europe—167 200 through 2013; 149 600 through 2012 Japan—199 800 through 2013; 187 000 through 2012 Latin America—4700 through 2013; 3900 through 2012 Middle East and Africa—14 900 through 2013; 12 400 through 2012 North America—208 000 through 2013; 191 400 through 2012 Number of patients treated per year: Asia excluding Japan—19 436 in 2013; 19 309 in 2012 Europe—17 672 in 2013; 16 081 in 2012 Japan—12 797 in 2013; 13 299 in 2012 Latin America—731 in 2013; 755 in 2012 Middle East and Africa—2462 in 2013; 1159 in 2012 North America—16 635 in 2013; 15 317 in 2012 |